NCT03827447View on ClinicalTrials.gov

Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

June 30, 2021

Conditions
Clostridium Difficile Infection
Interventions
DRUG

Vancomycin Oral Capsule

125 mg capsules every 6 hours for 14 days.

DRUG

Placebo Oral Capsule

Gelatin pill manufactured to mimic 125 mg Vancomycin oral capsule

Trial Locations (1)

53226

Medical College of Wisconsin, Inc., Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT03827447 - Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile | Biotech Hunter | Biotech Hunter